News

News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients ...
Agentic AI is not just another technological advancement; it is a paradigm shift that will redefine industries and elevate ...
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer ...
Among the companies displaying the strength of Chinese research in oncology at the 2025 ASCO Annual Meeting will be Hutchmed.
Researchers at NIT Rourkela have developed an innovative, semiconductor-based biosensor for early breast cancer detection.
Imagine waking up one morning with an unusual headache. Instead of frantically Googling symptoms or waiting hours at a clinic ...
A recent study in Science identifies a potential mechanism between linoleic acid (a type of omega-6) and a specific form of breast cancer, triple-negative. Spoiler alert: It does not confirm that seed ...
Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New ...
Researchers at UC San Diego, led by Professor Trey Ideker (right) are included in a $142 million initiative from ARPA-H with ...
CHICAGO -- Artificial intelligence (AI) assistance appeared to enhance pathologists' accuracy in identifying HER2-low or ...
AI-assisted training notably improved pathologist accuracy in HER2-low breast cancer, reducing misclassification and ...